Observational Evaluation of the Peristomal Skin Condition in Ostomates
OSMOSE
1 other identifier
observational
2,000
1 country
13
Brief Summary
The purpose of this study is to estimate the incidence and severity of peristomal skin lesions and evaluate the progression of the peristomal skin condition at 8-15 days following application of the barrier.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2012
Shorter than P25 for all trials
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 1, 2012
CompletedFirst Posted
Study publicly available on registry
February 6, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedDecember 17, 2012
December 1, 2012
11 months
February 1, 2012
December 14, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Peristomal skin condition
Change in peristomal skin condition from baseline as assessed with the SACS Instrument
At day 12
Secondary Outcomes (6)
Peristomal skin condition
at 1 month
Level of satisfaction
At 2 months
Accessory usage
Up to 2 months
Peristomal Skin Condition
At 2 months
Level of satisfaction
At 12 days
- +1 more secondary outcomes
Study Arms (2)
New moldable user
Subjects presenting with peristomal lesions with a traditional barrier and for whom a ConvaTec Moldable Technology™ Skin Barrier is used as a replacement.
New osomate
Subjects for whom a ConvaTec Moldable Technology™ Skin Barrier is used as the first long-term (within 7 days of ostomy surgery) system following surgery and have intact peristomal skin.
Eligibility Criteria
colostomates, ileostomates, urostomates in acute care settings or community at large.
You may qualify if:
- Subjects who are 18 years old and older.
- Subjects who agree to participate in the evaluation and who have signed the informed consent form.
- Subjects presenting with a stoma (ileostomy, colostomy or urostomy).
- Subjects for whom a ConvaTec Moldable Technology™ Skin Barrier per package insert is used as the first long-term (within 7 days of ostomy surgery) system following surgery and have intact peristomal skin.
- Subjects presenting with peristomal skin lesions using a traditional barrier and for whom a decision to replace the traditional barrier with ConvaTec Moldable Technology™ Skin Barrier per package insert is made in the context of routine clinical care.
You may not qualify if:
- Subjects who, according to the investigator, have cognitive problems that prevent them from answering a questionnaire or for whom the evaluation could be a problem.
- Subjects who are in a simultaneous clinical evaluation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ConvaTec Inc.lead
Study Sites (13)
Independent Nurse Consultant
Tucson, Arizona, 85742, United States
John Muir Health Concord Campus
Concord, California, 94520, United States
Conn. Clinical Nursing Associate, LLC
Plymoth, Connecticut, 06782, United States
Baptist Home Health
Jacksonville, Florida, 32207, United States
Porter Hospital
Valparaiso, Indiana, 46383, United States
Serena Group - Dr. Thomas Serena MD
Cambridge, Massachusetts, 02140, United States
Henry Ford Macomb Hospital
Clinton Township, Michigan, 48038, United States
Karmanos Cancer Center
Detroit, Michigan, 48201, United States
St. Anthony's Medical Center
St Louis, Missouri, 63128, United States
ID Med Inc.
Columbus, Ohio, 43222, United States
RI Colorectal Clinic, LLC
Pawtucket, Rhode Island, 02860, United States
San Jacinto Methodist Hospital
Baytown, Texas, 77521, United States
NW Pavillion Ostomy Clinic
Renton, Washington, 98055, United States
Study Officials
- STUDY CHAIR
Qing Li, Ph.D, MD
ConvaTec Inc.
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 1, 2012
First Posted
February 6, 2012
Study Start
January 1, 2012
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
December 17, 2012
Record last verified: 2012-12